A Divide & Conquer model decomposes the zero-inflated DAH endpoint into parts for better fit and simulation in clinical trial design.
Title resolution pending
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
stat.ME 1years
2026 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Beyond the Composite: Enhancing Trial Analysis through a Divide & Conquer Approach to 'Days Alive and at Home': Insights from the NOTACS trial
A Divide & Conquer model decomposes the zero-inflated DAH endpoint into parts for better fit and simulation in clinical trial design.